The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
Clinical trial NCT05005741 · UNKNOWN
Trial details
- NCT number
- NCT05005741
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2023-12-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.